Molecular Instruments, Inc.

Los Angeles, CA

UEI
SP8PV4N4ZED9
CAGE
88XN3
Primary NAICS
459999 All Other Miscellaneous Retailers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
5015 Eagle Rock Blvd #301, Los Angeles, CA 90041, USA
Website
molecularinstruments.com
Founded
2018
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Molecular Instruments, Inc.

Molecular Instruments, Inc. is a for-profit corporate entity specializing in the development and manufacturing of advanced scientific instruments and probes for biological research and imaging technologies. Based in Los Angeles, California, the company is registered in SAM.gov and focuses on creating sophisticated scientific equipment used primarily in biomedical research settings. The company produces specialized scientific products such as Hybridization Chain Reaction (HCR) amplifiers and probe sets, targeting research institutions and laboratories with cutting-edge molecular imaging technologies.

Through federal contract awards, Molecular Instruments, Inc. has predominantly secured small purchase order contracts with various National Institutes of Health (NIH) institutes, including the National Institute of Child Health and Human Development (NICHD), National Institute of Dental and Craniofacial Research, and the National Institute on Deafness and Other Communication Disorders. These contracts, typically ranging from $10,000 to $20,000, involve supplying scientific instruments like HCR amplifiers and probe sets. The contracts have been awarded without specific set-aside designations, indicating the company competes in open federal procurement processes. The purchase orders are primarily firm fixed-price contracts with completion dates spanning from 2021 to 2025.

Molecular Instruments, Inc. has been highly successful in securing federal grant awards, particularly from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program. The company has received multiple project grants totaling significant funding to advance probe technologies for RNA imaging. These grants focus on developing advanced technologies for ultrasensitive, multiplex RNA and protein imaging, with specific research goals including quantitative signal amplification, digital and analog mRNA quantitation, and automatic background suppression. The grant projects aim to overcome long-standing technological limitations in biological research by creating innovative imaging methods that enable more comprehensive and precise molecular imaging techniques across various biological samples, including whole-mount vertebrate embryos, thick brain slices, and formalin-fixed paraffin-embedded (FFPE) tissue sections.

Quick answers

What is Molecular Instruments, Inc.'s UEI?

Molecular Instruments, Inc.'s Unique Entity ID (UEI) in SAM.gov is SP8PV4N4ZED9.

What is Molecular Instruments, Inc.'s CAGE code?

Molecular Instruments, Inc.'s CAGE code is 88XN3.

What is Molecular Instruments, Inc.'s primary NAICS code?

Molecular Instruments, Inc.'s primary NAICS code is 459999 (All Other Miscellaneous Retailers).

Where is Molecular Instruments, Inc. located?

Molecular Instruments, Inc.'s physical address in SAM.gov is 5015 Eagle Rock Blvd #301, Los Angeles, CA 90041, USA.

Is Molecular Instruments, Inc. registered in SAM.gov?

Yes. Molecular Instruments, Inc.'s SAM.gov registration is active through November 5, 2026.

What is Molecular Instruments, Inc.'s most recent federal award?

Molecular Instruments, Inc.'s most recent federal grant award is Advancing probe technology for ultrasensitive RNA imaging via hybridization chain reaction - project summary advancing… (R43GM163490), from National Institute of General Medical Sciences, on September 30, 2025.

On GovTribe

See Molecular Instruments, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors